SG Americas Securities
OREX

SG Americas Securities’s Orexigen Therapeutics, Inc. OREX Stock Holding History

SG Americas Securities’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,833
Closed -$21K – 3648
2016
Q2 		$21K Sell
4,833
-8,603
-64% -$38.9K ﹤0.01% 2508
2016
Q1 		$76K Buy
+13,436
New +$174K ﹤0.01% 2692
2015
Q3 		– Sell
-1,097
Closed -$54K – 3089
2015
Q2 		$54K Buy
+1,097
New +$65.6K ﹤0.01% 2466
2015
Q1 		– Sell
-1,613
Closed -$98K – 3480
2014
Q4 		$98K Buy
+1,613
New +$81K ﹤0.01% 2931
2013
Q4 		– Sell
-2,311
Closed -$142K – 3447
2013
Q3 		$142K Buy
+2,311
New +$157K ﹤0.01% 2425

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SG Americas Securities's OREX Position: Q3 2016 in Review

SG Americas Securities sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2016, closing a stake of 4,833 shares — an estimated $21K sold.

SG Americas Securities first reported a position in OREX in Q3 2013 and held it in 5 quarters. The position peaked at $142K in Q3 2013. 55 funds tracked by Wall St. Rank hold OREX as of Q3 2016.

  • SG Americas Securities reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • SG Americas Securities sold 4,833 Orexigen Therapeutics, Inc. shares in Q3 2016, an estimated $21K.
  • SG Americas Securities first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and held it in 5 quarters.
  • SG Americas Securities's Orexigen Therapeutics, Inc. position peaked at $142K in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2016.

Based on SG Americas Securities's 13F filing for Q3 2016, filed 8 Nov 2016.